NeueHealth (NEUE) Competitors

NeueHealth (NYSE:NEUE) and Kingstone Companies (NASDAQ:KINS) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their institutional ownership, risk, community ranking, earnings, valuation, media sentiment, profitability, analyst recommendations and dividends.

Do analysts recommend NEUE or KINS?

NeueHealth currently has a consensus price target of $7.00, suggesting a potential upside of 2.64%. Kingstone Companies has a consensus price target of $6.50, suggesting a potential downside of 58.90%. Given NeueHealth's higher probable upside, equities analysts plainly believe NeueHealth is more favorable than Kingstone Companies.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
NeueHealth	0 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00
Kingstone Companies	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00

Does the media favor NEUE or KINS?

In the previous week, Kingstone Companies had 1 more articles in the media than NeueHealth. MarketBeat recorded 4 mentions for Kingstone Companies and 3 mentions for NeueHealth. Kingstone Companies' average media sentiment score of 1.20 beat NeueHealth's score of -0.86 indicating that Kingstone Companies is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
NeueHealth	0 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Negative
Kingstone Companies	3 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Do institutionals & insiders have more ownership in NEUE or KINS?

63.9% of NeueHealth shares are held by institutional investors. Comparatively, 14.9% of Kingstone Companies shares are held by institutional investors. 63.3% of NeueHealth shares are held by insiders. Comparatively, 12.2% of Kingstone Companies shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Which has higher valuation & earnings, NEUE or KINS?

Kingstone Companies has lower revenue, but higher earnings than NeueHealth. NeueHealth is trading at a lower price-to-earnings ratio than Kingstone Companies, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
NeueHealth	$907.35M	0.07	-$1.15B	-$22.00	-0.31
Kingstone Companies	$169.88M	1.28	-$6.17M	$1.59	9.95

Is NEUE or KINS more profitable?

Kingstone Companies has a net margin of 10.60% compared to NeueHealth's net margin of -36.28%. Kingstone Companies' return on equity of 32.55% beat NeueHealth's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
NeueHealth	-36.28%	-6.40%	8.45%
Kingstone Companies	10.60%	32.55%	4.27%

Which has more volatility and risk, NEUE or KINS?

NeueHealth has a beta of 0.53, suggesting that its stock price is 47% less volatile than the S&P 500. Comparatively, Kingstone Companies has a beta of 0.6, suggesting that its stock price is 40% less volatile than the S&P 500.

Does the MarketBeat Community favor NEUE or KINS?

Kingstone Companies received 193 more outperform votes than NeueHealth when rated by MarketBeat users. Likewise, 65.65% of users gave Kingstone Companies an outperform vote while only 0.00% of users gave NeueHealth an outperform vote.

Company	Underperform	Outperform
NeueHealth	Outperform Votes No Votes	Underperform Votes 2 100.00%
Kingstone Companies	Outperform Votes 193 65.65%	Underperform Votes 101 34.35%

Summary

Kingstone Companies beats NeueHealth on 13 of the 18 factors compared between the two stocks.